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ABSTRACT
Objective:  The aim of the present study was to acquire information on brachytherapy 
resources in Korea through a national survey of radiation oncologists.
Methods:  Between October 2014 and January 2015, a questionnaire on the current status 
of brachytherapy was distributed to all 86 radiation oncology departments in Korea. The 
questionnaire was divided into sections querying general information on human resources, 
brachytherapy equipment, and suggestions for future directions of brachytherapy policy in 
Korea.
Results:  The response rate of the survey was 88.3%. The average number of radiation 
oncologists per center was 2.3. At the time of survey, 28 centers (36.8%) provided 
brachytherapy to patients. Among the 28 brachytherapy centers, 15 (53.5%) were located in 
in the capital Seoul and its surrounding metropolitan areas. All brachytherapy centers had 
a high-dose rate system using 192Ir (26 centers) or 60Co (two centers). Among the 26 centers 
using 192Ir sources, 11 treated fewer than 40 patients per year. In the two centers using 60Co 
sources, the number of patients per year was 16 and 120, respectively. The most frequently 
cited difficulties in performing brachytherapy were cost related. A total of 21 centers had a 
plan to sustain the current brachytherapy system, and four centers noted plans to upgrade 
their brachytherapy system. Two centers stated that they were considering discontinuation of 
brachytherapy due to cost burdens of radioisotope source replacement.
Conclusion:  The present study illustrated the current status of brachytherapy in Korea. 
Financial difficulties were the major barriers to the practice of brachytherapy.
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INTRODUCTION
Brachytherapy in combination with external beam radiotherapy (EBRT) is an important 
radiotherapeutic modality for treating cancers of the cervix, prostate, breast, head and neck, 
respiratory tract, and digestive organs [1]. In brachytherapy, radioisotope sources can be 
positioned adjacent to the tumor site. A rapid dose fall-off around the radioactive sources 
in brachytherapy makes it possible to increase tumor control while sparing the surrounding 
organs [1]. Based on its therapeutic advantages, brachytherapy has been regarded as a 
standard treatment for several types of cancer, especially for cervical cancer and other 
gynecological cancers. Therefore, a large number of radiation treatment facilities have 
performed brachytherapy for several decades. The latest Korean survey in 2006 showed that 
65% of radiation oncology centers in Korea operate brachytherapy units [2].
However, the use of brachytherapy in Korea has been declining as the number of patients with 
cervical cancer has been decreasing. According to the Korea Central Cancer Registry, the age-
standardized incidence rate of cervical cancer per 100,000 persons fell from 16.3 in 1999 to 
10.6 in 2010, marking an average annual fall of 4.3% during the period [3]. Because cervical 
cancer is one of the most common indications for brachytherapy, the use of brachytherapy is 
speculated to be declining as the incidence of cervical cancer decreases. Nonetheless, there 
is insufficient information on the status of brachytherapy in Korea. In order to establish 
future brachytherapy policies in Korea, it is crucial to understand the current status of 
infrastructures and patterns of care for brachytherapy. The aim of the present study was 
to acquire information on brachytherapy resources in Korea through a national survey of 
radiation oncologists.
MATERIALS AND METHODS
Between October 2014 and January 2015, a questionnaire on the current status of 
brachytherapy was distributed to all 86 radiation oncology departments in Korea. The 
division of gynecologic cancer of the Korean Radiation Oncology Group (KROG) designed 
the questionnaire for distribution. The questionnaire was divided into the following three 
sections: general information including human resources, status of brachytherapy, and policy 
suggestions for brachytherapy.
Questions regarding personnel at each radiation oncology center were asked in the general 
information section. Infrastructure and the number of patients treated with brachytherapy 
at each center were examined in the brachytherapy status section. For radiation oncology 
centers without brachytherapy equipment, the questionnaire asked their policies in the 
management of patients requiring brachytherapy. In the future policy section, respondents 
were asked to comment on difficulties in operating brachytherapy centers and to state their 
plans for brachytherapy operations.
The survey was sent via email to the director of the Radiation Oncology Department in each 
hospital with a request to return the results to the researchers.
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RESULTS
Of the 86 radiation oncology departments, 76 completed the questionnaire and 10 did not 
respond to the request. Therefore, the response rate of the current survey was 88.3%.
1. Human resources
Among the 76 participating centers, which consisted of 63 academic and 13 non-academic 
centers, there were 247 board-certified radiation oncologists. The average number of 
radiation oncologists per center was 2.3 (95% CI, 1.9 to 2.8). A total of 52 centers (72.3%) 
had two or fewer radiation oncologists. Additionally, 68 radiation oncology residents were in 
the course of training in 20 centers (26.3%). There were 123 radiation oncology physicists in 
71 centers, while no physicists were present in five centers. The details of human resources in 
each center are presented in Table 1.
2. Status of brachytherapy
There were brachytherapy equipment installations in 32 radiation oncology centers. Among 
these 32 centers, 28 currently provide brachytherapy to patients while four had stopped 
performing brachytherapy at the time of survey. Consequently, brachytherapy is currently 
available in 36.8% (28 of 76) of the radiation oncology centers in Korea. The number of 
brachytherapy installations per million inhabitants is 0.55. In each brachytherapy center, 
there were one or two physicians specialized in brachytherapy. Each brachytherapy center 
had one brachytherapy treatment system. A regional distribution of the 28 brachytherapy 
centers is depicted in Fig. 1. All 28 centers perform high-dose rate (HDR) brachytherapy 
using iridium-192 (192Ir, 26 centers) or cobalt-60 (60Co, two centers). For centers using 192Ir, 
the intervals for radioisotope source replacement are between 3 and 10 months. Among the 
Table 1.  Distribution of human resources among 76 radiation oncology centers in Korea
Human resource No. (%)
Faculty in radiation oncology
   None 3 (3.9)
   1–2 52 (68.4)
   3–7 19 (25.0)
   ≥8 2 (2.7)
Fellow in radiation oncology
   None 48 (63.1)
   1 21 (27.6)
   ≥2 7 (9.2)
Radiation oncology residents
   None 56 (73.6)
   ≤2 13 (17.1)
   3–7 4 (5.2)
   ≥8 3 (4.1)
Radiation oncology physicists
   None 5 (6.6)
   1 54 (71.1)
   2–5 13 (17.1)
   ≥6 4 (5.2)
Dosimetrist
   None 43 (56.6)
   1 20 (26.3)
   2–3 9 (11.9)
   ≥4 4 (5.2)
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centers using 192Ir sources, 42.3% treated fewer than 40 patients over the last 12 months. In the 
two centers using 60Co sources, the number of patients per year was 16 and 120, respectively. In 
addition, 22 brachytherapy centers (78.5%) treated gynecological cancers only, while six centers 
(21.5%) used brachytherapy for other cancers in addition to gynecological cancers (Table 2). 
In treating gynecologic cancers, all 28 brachytherapy centers apply brachytherapy for cervical 
and endometrial cancers. For patients with cervical cancer, brachytherapy is used for definitive 
treatment (in 28 centers) and postoperative therapy (in 24 centers) in combination with external 
beam whole pelvic radiotherapy. For endometrial cancer, brachytherapy is administered 
as definitive treatment (in 18 centers) and postoperative treatment (in 28 centers). Various 
fractionation schedules are used in brachytherapy for cervical and endometrial cancers in the 
28 centers (Supplementary Tables 1, 2). A total of 31 patients with non-gynecological cancer 
were treated in the six centers over the last 12 months, with the number at each hospital 
ranging between 1 and 20.
There were 48 radiation oncology centers that do not perform brachytherapy. To manage 
patients requiring brachytherapy, 35 centers referred the patients to other hospitals for 
brachytherapy, while seven centers treated the patients either with EBRT as a substitute 
for brachytherapy or referred them to other brachytherapy centers. Asked if they had a 
brachytherapy center to where patients are often referred, 33 centers responded positively, 
while nine said they did not (Table 3).
Gangwon
2 units (0.65)
0 60 km
Gyeonggi
6 units (0.39)
Seoul
9 units (0.90)
Chungnam
1 units (0.29)
Chungbuk
0 units (0.00)
Jeonbuk
1 units (0.53)
Jeonnam
1 units (0.29)
Jeju
0 units (0.00)
Gyeongbuk
3 units (0.58)
Gyeongnam
5 units (0.62)
Fig. 1.  Regional distribution of the 28 brachytherapy centers in Korea. The value in parentheses presents 
brachytherapy equipment per million inhabitants in each region.Pr
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3. Future policy for brachytherapy
To understand hardships in operating brachytherapy centers, respondents were asked to 
verify difficulties in introducing or maintaining brachytherapy equipment. In the 48 radiation 
oncology centers not performing brachytherapy, high expenses for source replacement was 
the most frequent reason for not installing brachytherapy equipment. The most frequently 
cited difficulties in the operation of the 28 brachytherapy facilities were cost related (Table 4).
Table 2.  Status of brachytherapy among the 28 brachytherapy centers in Korea
Variable No. (%)
Equipment installation
   1980–1989 1 (3.5)
   1990–1999 5 (17.9)
   2000–2005 8 (28.6)
   2006–2010 7 (25.0)
   Later than 2011 6 (21.5)
   Not reported 1 (3.5)
Dose rate
   High-dose rate brachytherapy 28 (100.0)
   Low-dose rate brachytherapy 0
Radionuclides source
   192Ir 26 (92.8)
   60Co 2 (7.2)
Source replacement intervals (mo)
   For 192Ir
      3 1 (3.8)
      >3, <6 12 (46.2)
      6 12 (46.2)
      10 1 (3.8)
   For 60Co
      84 2 (100.0)
No. of patients (in centers using 192Ir)
   During last 6 mo
      ≤10 6 (23.1)
      11–30 13 (50.0)
      31–50 4 (15.4)
      51–60 2 (7.7)
      ≥ 61 1 (3.8)
   During last 12 mo
      ≤10 2 (7.7)
      11–40 9 (34.6)
      41–60 6 (23.1)
      61–100 5 (19.3)
      ≥100 3 (11.5)
      Not reported 1 (3.8)
No. of patients (in centers using 60Co)
   During last 6 mo
      10 1 (50.0)
      60 1 (50.0)
   During last 12 mo
      16 1 (50.0)
      120 1 (50.0)
Target cancer of brachytherapy
   Gynecological cancer only 22 (78.5)
   Gynecological and other types of cancer 6 (21.5)
192Ir, iridium-192; 60Co, cobalt-60.
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Asked to identify their future plans for introducing brachytherapy, 42 of the 48 radiation 
oncology centers that do not practice brachytherapy provided responses. A total of 26 centers 
(54.2%) said that they would not install brachytherapy equipment, whereas 16 centers (33.3%) 
considered introducing brachytherapy as long as the treatment would generate profit or 
if departmental revenues would cover expenses. Meanwhile, among the 28 brachytherapy 
centers, 27 stated their plans for brachytherapy. Of these, 21 centers (75.0%) said they will 
sustain the current brachytherapy system, four (14.4%) noted plans to upgrade the system, 
and two (7.2%) answered that they considered discontinuing brachytherapy due to cost 
burdens of radioisotope source replacement.
To formulate future policies for brachytherapy, all 76 respondents were asked to choose at 
least one suggestion among the following: (1) maintain the present brachytherapy policy; (2) 
raise the medical fee for brachytherapy; and (3) designate regional brachytherapy centers and 
request government subsidies. The frequencies of selection of each answer were 3, 42, and 
42, respectively.
Table 3.  Management of patients who need brachytherapy in 48 radiation oncology centers not performing 
brachytherapy
Management method No. of centers (%)
Refer to other hospital for brachytherapy 35 (72.9)
   Have frequently-referred brachytherapy centers 29 (60.4)
   Do not have frequently-referred brachytherapy centers 6 (12.5)
Use external beam radiotherapy or refer to brachytherapy center 7 (14.6)
   Have frequently-referred brachytherapy centers 4 (8.3)
   Do not have frequently-referred brachytherapy centers 3 (6.3)
Not replied 6 (12.5)
Table 4.  Opinions of radiation oncologists regarding operation of brachytherapy center
Opinion Frequency*
Difficulties in maintaining brachytherapy center (among 28 brachytherapy centers) 
   Too low medical reimbursement 27
   Too high expenses for source replacement 23
   Shortage of human resources 13
   Concerns about accidents 2
   Decreasing number of patients 1
   Obsolete brachytherapy equipment 1
Causes for not installing brachytherapy equipment (among 48 centers not performing 
brachytherapy)
   Too low medical reimbursement 26
   Too high expenses for source replacement 29
   Shortage of human resources 25
   Absence of dedicated room for brachytherapy 14
   Decreasing number of patients 9
   Not permitted by hospital authority 5
   Physician’s personal decision 
      Concerns about accidents 3
      Burden of invasive technique 2
      Lack of brachytherapy experience 2
* Multiple choices were allowed in selection of answers.Pr
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DISCUSSION
The present study is the first to investigate the current status of brachytherapy in Korea 
through a national survey of radiation oncologists. As of January 2015, only 32.5% of Korean 
radiation oncology centers could provide brachytherapy to patients. All centers had a HDR 
brachytherapy system, and about 43% of the brachytherapy centers treated fewer than 40 
patients per year. Further, more than 70% of the centers applied brachytherapy only to the 
patients with gynecological cancers. For radiation oncology centers without brachytherapy 
equipment, the most common response for not having brachytherapy equipment was high 
expenses for replacement of the radionuclides source.
Notably, the number of brachytherapy centers and the proportion of Korean radiation 
oncology centers offering brachytherapy have decreased since 2006. According to reports by 
the Korean Society for Radiation Oncology, there were 39 brachytherapy centers among 60 
radiation oncology centers in 2006 [2,4]. In the current survey, a total of 28 brachytherapy 
centers were identified among 76 radiation oncology centers, showing a 28.2% decrease 
since 2006 (Fig. 2). In addition, the number of brachytherapy units per million inhabitants 
fell from 0.79 to 0.55 between 2006 and 2014. We have also found that the brachytherapy 
centers are unevenly distributed across the regions of Korea. A total of 53.5% (15 of 28) 
brachytherapy centers are located in the capital Seoul and its surrounding metropolitan 
areas. Outside the metropolitan area, fewer than three brachytherapy centers were identified 
in each province, except in Gyeongnam province, which includes Busan, the second largest 
city in Korea. Moreover, no brachytherapy units are installed in Chungbuk province and the 
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Fig. 2.  The total number of radiation oncology centers and brachytherapy centers in Korea by year. Information 
on faculty in 1997, 2006, and 2012 were provided by the Korean Society for Radiation Oncology. Data from Ji et 
al. [2] and The Korean Society for Radiation Oncology [4]
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province of Jeju Island. Thus, regional patients who opt for brachytherapy will incur travel and 
accommodation expenses.
The proportion of radiation oncology centers offering brachytherapy is lower in comparison 
to other countries. According to studies, the number of brachytherapy centers is 29 in the 
United Kingdom, 39 in Spain [5], 30 in Canada [6], and 125 in Germany [7]. The proportions 
of brachytherapy centers in Canada, Europe, and Latin America have been listed as 90.9%, 
60.3%, and 50.6%, respectively [6-9]. Because the year of data acquisition and the rate of 
response to the surveys were different among the studies, one cannot directly compare 
the availability of brachytherapy in Korea to other countries using this data. However, the 
availability of brachytherapy has become worse over the last two decades because of a rapid 
decrease in the number of brachytherapy centers and an uneven regional distribution of units.
The low proportion of brachytherapy centers raises the possibility of providing inadequate 
treatments for tumor, particularly for cancer in the intact uterine cervix. Patients with 
cancer in the intact uterine cervix should be treated with EBRT along with brachytherapy. In 
cases where a patient with cancer in the intact cervix receives EBRT in a radiotherapy center 
without brachytherapy equipment, the patient should be transferred to another center for 
brachytherapy. Because almost two thirds of radiation oncology centers in Korea do not 
have brachytherapy equipment, a large number of patients with cervical cancer should have 
such a referral. However, there are no well-organized referral systems in Korean radiation 
oncology centers. A total of 18.8% (9 of 48) radiation oncology centers without brachytherapy 
equipment did not have any pre-established network to brachytherapy centers. Even in 
the radiation oncology centers that have outside links to brachytherapy centers, radiation 
oncologists have no formal role beyond providing patients with information about hospitals 
with a brachytherapy center. Moreover, 14.6% (7 of 48) of the surveyed centers replied that 
they had cases treated with EBRT instead of brachytherapy. In treating cancer of the intact 
uterine cervix, brachytherapy is an essential treatment. Not providing brachytherapy is 
detrimental to the survival of patients with cervical cancer [10,11]. In addition, extending the 
overall duration of radiotherapy to more than 56 days has been reported to be significantly 
associated with an increased risk of pelvic failure in concurrent chemoradiotherapy for 
cervical cancer [12]. Therefore, it is crucial to build a well-organized referral system to 
expedite patient referral.
Of note, most of the surveyed radiation oncology centers applied brachytherapy only 
to patients with gynecological cancers. Even the centers that performed brachytherapy 
for patients with non-gynecological cancers treated fewer than 20 such patients in a 
year. Moreover, there were only 31 patients with non-gynecological cancers treated with 
brachytherapy in a year among all responding radiation oncology centers in the current study. 
Given that more than 40% of brachytherapy in other countries is applied to non-gynecological 
cancers, such as the prostate or breast cancer, it is worth broadening the application of 
brachytherapy in Korea [6,8].
In Korea, the medical reimbursement system is strictly controlled by the government. No 
private medical reimbursement system is allowed. Even though there is an annual negotiation 
between the government and organizations of health care providers, increases in charges 
are almost always set according to restrictions suggested by the government. The Korean 
Society of Radiation Oncology tried to raise teletherapy charges, rather than brachytherapy, 
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owing to a dramatic rise in the provision of teletherapy and rapid decrease in prescriptions 
of brachytherapy. Consequently, insufficient reimbursement was the most frequently noted 
barrier to installing and sustaining brachytherapy centers. For intracavitary brachytherapy 
with 5 to 15 fractions, including simulation and planning, the Korean National Health 
Insurance reimburses 1,300,000 Korean won (KRW) or about 1,213 US $ (using the 2014 
average exchange rate of 1,071 KRW to the US $) [13]. The 1,300,000 KRW includes 
expenses for source replacement as well as procedure costs. Because most brachytherapy 
is completed within 15 fractions, a radiotherapy center will be paid a total of 1,300,000 
KRW for the entire course of brachytherapy per patient. In brachytherapy centers using 192Ir 
sources, the source should be changed four times per year, considering that the half-life of 
192Ir is 74 days [14]. The purchase cost of 192Ir is about 13,000,000 KRW per replacement in 
Korea. Therefore, at least 40 new patients a year are necessary for cost-effective operation 
of the 192Ir brachytherapy centers. All but two Korean brachytherapy centers adopted 192Ir 
sources, and 42.3% of the centers treated fewer than 40 patients per year. Under the current 
circumstances, most Korean brachytherapy centers are expected to suffer a deficit for the 
operation of brachytherapy. Indeed, four radiation oncology centers ceased to operate 
brachytherapy due to the high expenses of source exchange compared to the reimbursement.
To overcome such a deficit caused by an imbalance of fee-to-source expenses, several centers 
exchanged the 192Ir source fewer than four times a year. Only one brachytherapy center 
changed 192Ir sources within 3 months, while half of the centers replaced the source every 
6 months. A longer interval of 192Ir source replacement than 3 months causes low source 
strength, decreasing dose rate and increasing treatment times, creating a vicious cycle of 
inefficiency, leading to therapeutically inferior results. To provide high quality brachytherapy 
to patients, it is necessary to set adequate brachytherapy fees that can cover the source 
replacement expense. In the Medicare reimbursement of the Unites States, the cost of 
radionuclide sources is charged in addition to fees for brachytherapy simulation, planning, 
image guidance, procedures, and medical physics consultation [15]. Korean radiation 
oncologists expressed in the current survey that the national reimbursement system needs to 
be similarly adjusted to cover the expenses of radionuclide sources.
At present, only a third of Korean radiation oncology centers can provide brachytherapy to 
patients. Given the finite brachytherapy resources, it is important to use them efficiently 
while maintaining high-quality brachytherapy. To provide patients with properly qualified 
brachytherapy, the respondents to the current survey suggested constructing referring 
networks of brachytherapy with designated referral centers by region. According to experts, 
centers treating low number of patients should refer the patients to larger centers for 
brachytherapy as continued practice of brachytherapy is needed to maintain skills [16,17]. 
Given that about 7% of brachytherapy centers in Korea treated fewer than 10 patients per 
year, the referral networks are also necessary for brachytherapy centers with a low volume 
of patients. With well-organized referral networks, patients are expected to have timely 
brachytherapy without treatment delay. To set up such a system, it is necessary to estimate 
how many patients are referred to another hospital for brachytherapy. To facilitate patient’s 
referral and to maintain high quality of treatment, some financial support might be helpful 
for brachytherapy referral centers. The KROG and Ministry of Health and Welfare should 
cooperate in constructing the referring networks for brachytherapy in the future.
In conclusion, the present study shed light on the current status of brachytherapy in Korea, 
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focusing on the resources and facilities available. The quantity of brachytherapy resources is 
decreasing and these resources are distributed unequally across Korea. Financial difficulties 
were the major barriers to the practice of brachytherapy in Korean radiation oncology centers. 
Given the limited resources available, a network linking base brachytherapy centers was 
proposed, to facilitate referring patients in timely fashion.
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